The global market for Human Bloodm Albumin was valued at US$ 6375 million in the year 2024 and is projected to reach a revised size of US$ 9817 million by 2031, growing at a CAGR of 6.5% during the forecast period.

Human Bloodm Albumin Market

Human blood albumin is a plasma protein produced by the liver that plays a crucial role in maintaining oncotic pressure, transporting hormones, fatty acids, and other substances, and regulating blood volume. It is commonly used in medical treatments for conditions such as hypovolemia, burns, shock, and hypoalbuminemia. Human blood albumin is derived from donated human plasma and is purified for therapeutic use in hospitals and medical facilities. Due to its essential function in stabilizing blood circulation, it is widely used in critical care and surgical procedures.

The Human Bloodm Albumin market is driven by the increasing prevalence of liver diseases, nephrotic syndrome, and hypoalbuminemia, which require albumin-based therapies. Additionally, Human Bloodm Albumin is widely used in critical care settings for treating burns, shock, and surgical recovery, boosting its demand. The expanding applications of albumin in biopharmaceuticals, including drug delivery, vaccine formulation, and regenerative medicine, further fuel market growth. Rising healthcare expenditures, improvements in plasma collection infrastructure, and growing demand in emerging markets like China and India contribute to the industry's expansion.

However, the market faces challenges such as limited plasma supply and high production costs, as Human Bloodm Albumin is primarily derived from human plasma, which is subject to stringent donation regulations. Stringent government policies and safety concerns regarding pathogen transmission also hinder market growth. Additionally, competition from synthetic and recombinant Human Bloodm Albumin is increasing, though high production costs and market acceptance remain barriers. Overcoming supply chain constraints and advancing rHSA technologies will be crucial for sustaining growth in the global Human Bloodm Albumin market.

The key global producers of Human Bloodm Albumin are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, and Shanghai RAAS, with the top four manufacturers together holding 60% of the market share. The largest producer is CSL with a market share of 21.25%. In terms of consumption level, the market is mainly distributed in North America, Europe and Asia Pacific, with Asia Pacific having the highest market share of 68.63%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Bloodm Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Bloodm Albumin.

The Human Bloodm Albumin market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Bloodm Albumin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Bloodm Albumin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Bloodm Albumin Market Report

Report Metric	Details
Report Name	Human Bloodm Albumin Market
Accounted market size in year	US$ 6375 million
Forecasted market size in 2031	US$ 9817 million
CAGR	6.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	20-25% Concentrations 5% Concentrations
Segment by Application	Therapeutics Excipient Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, Shanghai RAAS, LFB Group, Weiguang Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Bloodm Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Bloodm Albumin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Human Bloodm Albumin Market growing?

Ans: The Human Bloodm Albumin Market witnessing a CAGR of 6.5% during the forecast period 2025-2031.

What is the Human Bloodm Albumin Market size in 2031?

Ans: The Human Bloodm Albumin Market size in 2031 will be US$ 9817 million.

What is the market share of major companies in Human Bloodm Albumin Market?

Ans: The key global producers of Human Bloodm Albumin are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, and Shanghai RAAS, with the top four manufacturers together holding 60% of the market share.

What is the CSL share in Human Bloodm Albumin Market?

Ans: The largest producer is CSL with a market share of 21.25%.

Who are the main players in the Human Bloodm Albumin Market report?

Ans: The main players in the Human Bloodm Albumin Market are Grifols, CSL, Takeda, Octapharma, CBPO, Hualan Bio, Kedrion, Shanghai RAAS, LFB Group, Weiguang Bio, Tiantan Bio, Shuanglin Bio, Boya Bio, Yuanda Shuyang

What are the Application segmentation covered in the Human Bloodm Albumin Market report?

Ans: The Applications covered in the Human Bloodm Albumin Market report are Therapeutics, Excipient, Other

What are the Type segmentation covered in the Human Bloodm Albumin Market report?

Ans: The Types covered in the Human Bloodm Albumin Market report are 20-25% Concentrations, 5% Concentrations

1 Human Bloodm Albumin Market Overview

1.1 Product Definition

1.2 Human Bloodm Albumin by Type

1.2.1 Global Human Bloodm Albumin Market Value Comparison by Type (2024 VS 2031)

1.2.2 20-25% Concentrations

1.2.3 5% Concentrations

1.3 Human Bloodm Albumin by Application

1.3.1 Global Human Bloodm Albumin Market Value by Application (2024 VS 2031)

1.3.2 Therapeutics

1.3.3 Excipient

1.3.4 Other

1.4 Global Human Bloodm Albumin Market Size Estimates and Forecasts

1.4.1 Global Human Bloodm Albumin Revenue 2020-2031

1.4.2 Global Human Bloodm Albumin Sales 2020-2031

1.4.3 Global Human Bloodm Albumin Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Human Bloodm Albumin Market Competition by Manufacturers

2.1 Global Human Bloodm Albumin Sales Market Share by Manufacturers (2020-2025)

2.2 Global Human Bloodm Albumin Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Human Bloodm Albumin Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Human Bloodm Albumin, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Human Bloodm Albumin, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Human Bloodm Albumin, Product Type & Application

2.7 Global Key Manufacturers of Human Bloodm Albumin, Date of Enter into This Industry

2.8 Global Human Bloodm Albumin Market Competitive Situation and Trends

2.8.1 Global Human Bloodm Albumin Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Human Bloodm Albumin Players Market Share by Revenue

2.8.3 Global Human Bloodm Albumin Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Human Bloodm Albumin Market Scenario by Region

3.1 Global Human Bloodm Albumin Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Human Bloodm Albumin Sales by Region: 2020-2031

3.2.1 Global Human Bloodm Albumin Sales by Region: 2020-2025

3.2.2 Global Human Bloodm Albumin Sales by Region: 2026-2031

3.3 Global Human Bloodm Albumin Revenue by Region: 2020-2031

3.3.1 Global Human Bloodm Albumin Revenue by Region: 2020-2025

3.3.2 Global Human Bloodm Albumin Revenue by Region: 2026-2031

3.4 North America Human Bloodm Albumin Market Facts & Figures by Country

3.4.1 North America Human Bloodm Albumin Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Human Bloodm Albumin Sales by Country (2020-2031)

3.4.3 North America Human Bloodm Albumin Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Human Bloodm Albumin Market Facts & Figures by Country

3.5.1 Europe Human Bloodm Albumin Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Human Bloodm Albumin Sales by Country (2020-2031)

3.5.3 Europe Human Bloodm Albumin Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Human Bloodm Albumin Market Facts & Figures by Region

3.6.1 Asia Pacific Human Bloodm Albumin Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Human Bloodm Albumin Sales by Region (2020-2031)

3.6.3 Asia Pacific Human Bloodm Albumin Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Human Bloodm Albumin Market Facts & Figures by Country

3.7.1 Latin America Human Bloodm Albumin Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Human Bloodm Albumin Sales by Country (2020-2031)

3.7.3 Latin America Human Bloodm Albumin Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Human Bloodm Albumin Market Facts & Figures by Country

3.8.1 Middle East and Africa Human Bloodm Albumin Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Human Bloodm Albumin Sales by Country (2020-2031)

3.8.3 Middle East and Africa Human Bloodm Albumin Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Human Bloodm Albumin Sales by Type (2020-2031)

4.1.1 Global Human Bloodm Albumin Sales by Type (2020-2025)

4.1.2 Global Human Bloodm Albumin Sales by Type (2026-2031)

4.1.3 Global Human Bloodm Albumin Sales Market Share by Type (2020-2031)

4.2 Global Human Bloodm Albumin Revenue by Type (2020-2031)

4.2.1 Global Human Bloodm Albumin Revenue by Type (2020-2025)

4.2.2 Global Human Bloodm Albumin Revenue by Type (2026-2031)

4.2.3 Global Human Bloodm Albumin Revenue Market Share by Type (2020-2031)

4.3 Global Human Bloodm Albumin Price by Type (2020-2031)

5 Segment by Application

5.1 Global Human Bloodm Albumin Sales by Application (2020-2031)

5.1.1 Global Human Bloodm Albumin Sales by Application (2020-2025)

5.1.2 Global Human Bloodm Albumin Sales by Application (2026-2031)

5.1.3 Global Human Bloodm Albumin Sales Market Share by Application (2020-2031)

5.2 Global Human Bloodm Albumin Revenue by Application (2020-2031)

5.2.1 Global Human Bloodm Albumin Revenue by Application (2020-2025)

5.2.2 Global Human Bloodm Albumin Revenue by Application (2026-2031)

5.2.3 Global Human Bloodm Albumin Revenue Market Share by Application (2020-2031)

5.3 Global Human Bloodm Albumin Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Grifols

6.1.1 Grifols Company Information

6.1.2 Grifols Description and Business Overview

6.1.3 Grifols Human Bloodm Albumin Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Grifols Human Bloodm Albumin Product Portfolio

6.1.5 Grifols Recent Developments/Updates

6.2 CSL

6.2.1 CSL Company Information

6.2.2 CSL Description and Business Overview

6.2.3 CSL Human Bloodm Albumin Sales, Revenue and Gross Margin (2020-2025)

6.2.4 CSL Human Bloodm Albumin Product Portfolio

6.2.5 CSL Recent Developments/Updates

6.3 Takeda

6.3.1 Takeda Company Information

6.3.2 Takeda Description and Business Overview

6.3.3 Takeda Human Bloodm Albumin Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Takeda Human Bloodm Albumin Product Portfolio

6.3.5 Takeda Recent Developments/Updates

6.4 Octapharma

6.4.1 Octapharma Company Information

6.4.2 Octapharma Description and Business Overview

6.4.3 Octapharma Human Bloodm Albumin Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Octapharma Human Bloodm Albumin Product Portfolio

6.4.5 Octapharma Recent Developments/Updates

6.5 CBPO

6.5.1 CBPO Company Information

6.5.2 CBPO Description and Business Overview

6.5.3 CBPO Human Bloodm Albumin Sales, Revenue and Gross Margin (2020-2025)

6.5.4 CBPO Human Bloodm Albumin Product Portfolio

6.5.5 CBPO Recent Developments/Updates

6.6 Hualan Bio

6.6.1 Hualan Bio Company Information

6.6.2 Hualan Bio Description and Business Overview

6.6.3 Hualan Bio Human Bloodm Albumin Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Hualan Bio Human Bloodm Albumin Product Portfolio

6.6.5 Hualan Bio Recent Developments/Updates

6.7 Kedrion

6.7.1 Kedrion Company Information

6.7.2 Kedrion Description and Business Overview

6.7.3 Kedrion Human Bloodm Albumin Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Kedrion Human Bloodm Albumin Product Portfolio

6.7.5 Kedrion Recent Developments/Updates

6.8 Shanghai RAAS

6.8.1 Shanghai RAAS Company Information

6.8.2 Shanghai RAAS Description and Business Overview

6.8.3 Shanghai RAAS Human Bloodm Albumin Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Shanghai RAAS Human Bloodm Albumin Product Portfolio

6.8.5 Shanghai RAAS Recent Developments/Updates

6.9 LFB Group

6.9.1 LFB Group Company Information

6.9.2 LFB Group Description and Business Overview

6.9.3 LFB Group Human Bloodm Albumin Sales, Revenue and Gross Margin (2020-2025)

6.9.4 LFB Group Human Bloodm Albumin Product Portfolio

6.9.5 LFB Group Recent Developments/Updates

6.10 Weiguang Bio

6.10.1 Weiguang Bio Company Information

6.10.2 Weiguang Bio Description and Business Overview

6.10.3 Weiguang Bio Human Bloodm Albumin Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Weiguang Bio Human Bloodm Albumin Product Portfolio

6.10.5 Weiguang Bio Recent Developments/Updates

6.11 Tiantan Bio

6.11.1 Tiantan Bio Company Information

6.11.2 Tiantan Bio Description and Business Overview

6.11.3 Tiantan Bio Human Bloodm Albumin Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Tiantan Bio Human Bloodm Albumin Product Portfolio

6.11.5 Tiantan Bio Recent Developments/Updates

6.12 Shuanglin Bio

6.12.1 Shuanglin Bio Company Information

6.12.2 Shuanglin Bio Description and Business Overview

6.12.3 Shuanglin Bio Human Bloodm Albumin Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Shuanglin Bio Human Bloodm Albumin Product Portfolio

6.12.5 Shuanglin Bio Recent Developments/Updates

6.13 Boya Bio

6.13.1 Boya Bio Company Information

6.13.2 Boya Bio Description and Business Overview

6.13.3 Boya Bio Human Bloodm Albumin Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Boya Bio Human Bloodm Albumin Product Portfolio

6.13.5 Boya Bio Recent Developments/Updates

6.14 Yuanda Shuyang

6.14.1 Yuanda Shuyang Company Information

6.14.2 Yuanda Shuyang Description and Business Overview

6.14.3 Yuanda Shuyang Human Bloodm Albumin Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Yuanda Shuyang Human Bloodm Albumin Product Portfolio

6.14.5 Yuanda Shuyang Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Human Bloodm Albumin Industry Chain Analysis

7.2 Human Bloodm Albumin Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Human Bloodm Albumin Production Mode & Process Analysis

7.4 Human Bloodm Albumin Sales and Marketing

7.4.1 Human Bloodm Albumin Sales Channels

7.4.2 Human Bloodm Albumin Distributors

7.5 Human Bloodm Albumin Customer Analysis

8 Human Bloodm Albumin Market Dynamics

8.1 Human Bloodm Albumin Industry Trends

8.2 Human Bloodm Albumin Market Drivers

8.3 Human Bloodm Albumin Market Challenges

8.4 Human Bloodm Albumin Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Human Bloodm Albumin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Human Bloodm Albumin Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Human Bloodm Albumin Market Competitive Situation by Manufacturers in 2024

Table 4. Global Human Bloodm Albumin Sales (MT) of Key Manufacturers (2020-2025)

Table 5. Global Human Bloodm Albumin Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Human Bloodm Albumin Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Human Bloodm Albumin Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Human Bloodm Albumin Average Price (US$/Kg) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Human Bloodm Albumin, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Human Bloodm Albumin, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Human Bloodm Albumin, Product Type & Application

Table 12. Global Key Manufacturers of Human Bloodm Albumin, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Human Bloodm Albumin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Bloodm Albumin as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Human Bloodm Albumin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Human Bloodm Albumin Sales by Region (2020-2025) & (MT)

Table 18. Global Human Bloodm Albumin Sales Market Share by Region (2020-2025)

Table 19. Global Human Bloodm Albumin Sales by Region (2026-2031) & (MT)

Table 20. Global Human Bloodm Albumin Sales Market Share by Region (2026-2031)

Table 21. Global Human Bloodm Albumin Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Human Bloodm Albumin Revenue Market Share by Region (2020-2025)

Table 23. Global Human Bloodm Albumin Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Human Bloodm Albumin Revenue Market Share by Region (2026-2031)

Table 25. North America Human Bloodm Albumin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Human Bloodm Albumin Sales by Country (2020-2025) & (MT)

Table 27. North America Human Bloodm Albumin Sales by Country (2026-2031) & (MT)

Table 28. North America Human Bloodm Albumin Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Human Bloodm Albumin Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Human Bloodm Albumin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Human Bloodm Albumin Sales by Country (2020-2025) & (MT)

Table 32. Europe Human Bloodm Albumin Sales by Country (2026-2031) & (MT)

Table 33. Europe Human Bloodm Albumin Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Human Bloodm Albumin Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Human Bloodm Albumin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Human Bloodm Albumin Sales by Region (2020-2025) & (MT)

Table 37. Asia Pacific Human Bloodm Albumin Sales by Region (2026-2031) & (MT)

Table 38. Asia Pacific Human Bloodm Albumin Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Human Bloodm Albumin Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Human Bloodm Albumin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Human Bloodm Albumin Sales by Country (2020-2025) & (MT)

Table 42. Latin America Human Bloodm Albumin Sales by Country (2026-2031) & (MT)

Table 43. Latin America Human Bloodm Albumin Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Human Bloodm Albumin Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Human Bloodm Albumin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Human Bloodm Albumin Sales by Country (2020-2025) & (MT)

Table 47. Middle East and Africa Human Bloodm Albumin Sales by Country (2026-2031) & (MT)

Table 48. Middle East and Africa Human Bloodm Albumin Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Human Bloodm Albumin Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Human Bloodm Albumin Sales (MT) by Type (2020-2025)

Table 51. Global Human Bloodm Albumin Sales (MT) by Type (2026-2031)

Table 52. Global Human Bloodm Albumin Sales Market Share by Type (2020-2025)

Table 53. Global Human Bloodm Albumin Sales Market Share by Type (2026-2031)

Table 54. Global Human Bloodm Albumin Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Human Bloodm Albumin Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Human Bloodm Albumin Revenue Market Share by Type (2020-2025)

Table 57. Global Human Bloodm Albumin Revenue Market Share by Type (2026-2031)

Table 58. Global Human Bloodm Albumin Price (US$/Kg) by Type (2020-2025)

Table 59. Global Human Bloodm Albumin Price (US$/Kg) by Type (2026-2031)

Table 60. Global Human Bloodm Albumin Sales (MT) by Application (2020-2025)

Table 61. Global Human Bloodm Albumin Sales (MT) by Application (2026-2031)

Table 62. Global Human Bloodm Albumin Sales Market Share by Application (2020-2025)

Table 63. Global Human Bloodm Albumin Sales Market Share by Application (2026-2031)

Table 64. Global Human Bloodm Albumin Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Human Bloodm Albumin Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Human Bloodm Albumin Revenue Market Share by Application (2020-2025)

Table 67. Global Human Bloodm Albumin Revenue Market Share by Application (2026-2031)

Table 68. Global Human Bloodm Albumin Price (US$/Kg) by Application (2020-2025)

Table 69. Global Human Bloodm Albumin Price (US$/Kg) by Application (2026-2031)

Table 70. Grifols Company Information

Table 71. Grifols Description and Business Overview

Table 72. Grifols Human Bloodm Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 73. Grifols Human Bloodm Albumin Product

Table 74. Grifols Recent Developments/Updates

Table 75. CSL Company Information

Table 76. CSL Description and Business Overview

Table 77. CSL Human Bloodm Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 78. CSL Human Bloodm Albumin Product

Table 79. CSL Recent Developments/Updates

Table 80. Takeda Company Information

Table 81. Takeda Description and Business Overview

Table 82. Takeda Human Bloodm Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 83. Takeda Human Bloodm Albumin Product

Table 84. Takeda Recent Developments/Updates

Table 85. Octapharma Company Information

Table 86. Octapharma Description and Business Overview

Table 87. Octapharma Human Bloodm Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 88. Octapharma Human Bloodm Albumin Product

Table 89. Octapharma Recent Developments/Updates

Table 90. CBPO Company Information

Table 91. CBPO Description and Business Overview

Table 92. CBPO Human Bloodm Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 93. CBPO Human Bloodm Albumin Product

Table 94. CBPO Recent Developments/Updates

Table 95. Hualan Bio Company Information

Table 96. Hualan Bio Description and Business Overview

Table 97. Hualan Bio Human Bloodm Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 98. Hualan Bio Human Bloodm Albumin Product

Table 99. Hualan Bio Recent Developments/Updates

Table 100. Kedrion Company Information

Table 101. Kedrion Description and Business Overview

Table 102. Kedrion Human Bloodm Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 103. Kedrion Human Bloodm Albumin Product

Table 104. Kedrion Recent Developments/Updates

Table 105. Shanghai RAAS Company Information

Table 106. Shanghai RAAS Description and Business Overview

Table 107. Shanghai RAAS Human Bloodm Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 108. Shanghai RAAS Human Bloodm Albumin Product

Table 109. Shanghai RAAS Recent Developments/Updates

Table 110. LFB Group Company Information

Table 111. LFB Group Description and Business Overview

Table 112. LFB Group Human Bloodm Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 113. LFB Group Human Bloodm Albumin Product

Table 114. LFB Group Recent Developments/Updates

Table 115. Weiguang Bio Company Information

Table 116. Weiguang Bio Description and Business Overview

Table 117. Weiguang Bio Human Bloodm Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 118. Weiguang Bio Human Bloodm Albumin Product

Table 119. Weiguang Bio Recent Developments/Updates

Table 120. Tiantan Bio Company Information

Table 121. Tiantan Bio Description and Business Overview

Table 122. Tiantan Bio Human Bloodm Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 123. Tiantan Bio Human Bloodm Albumin Product

Table 124. Tiantan Bio Recent Developments/Updates

Table 125. Shuanglin Bio Company Information

Table 126. Shuanglin Bio Description and Business Overview

Table 127. Shuanglin Bio Human Bloodm Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 128. Shuanglin Bio Human Bloodm Albumin Product

Table 129. Shuanglin Bio Recent Developments/Updates

Table 130. Boya Bio Company Information

Table 131. Boya Bio Description and Business Overview

Table 132. Boya Bio Human Bloodm Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 133. Boya Bio Human Bloodm Albumin Product

Table 134. Boya Bio Recent Developments/Updates

Table 135. Yuanda Shuyang Company Information

Table 136. Yuanda Shuyang Description and Business Overview

Table 137. Yuanda Shuyang Human Bloodm Albumin Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)

Table 138. Yuanda Shuyang Human Bloodm Albumin Product

Table 139. Yuanda Shuyang Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Human Bloodm Albumin Distributors List

Table 143. Human Bloodm Albumin Customers List

Table 144. Human Bloodm Albumin Market Trends

Table 145. Human Bloodm Albumin Market Drivers

Table 146. Human Bloodm Albumin Market Challenges

Table 147. Human Bloodm Albumin Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Human Bloodm Albumin

Figure 2. Global Human Bloodm Albumin Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Human Bloodm Albumin Market Share by Type: 2024 & 2031

Figure 4. 20-25% Concentrations Product Picture

Figure 5. 5% Concentrations Product Picture

Figure 6. Global Human Bloodm Albumin Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Human Bloodm Albumin Market Share by Application: 2024 & 2031

Figure 8. Therapeutics

Figure 9. Excipient

Figure 10. Other

Figure 11. Global Human Bloodm Albumin Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Human Bloodm Albumin Market Size (2020-2031) & (US$ Million)

Figure 13. Global Human Bloodm Albumin Sales (2020-2031) & (MT)

Figure 14. Global Human Bloodm Albumin Average Price (US$/Kg) & (2020-2031)

Figure 15. Human Bloodm Albumin Report Years Considered

Figure 16. Human Bloodm Albumin Sales Share by Manufacturers in 2024

Figure 17. Global Human Bloodm Albumin Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Human Bloodm Albumin Players: Market Share by Revenue in Human Bloodm Albumin in 2024

Figure 19. Human Bloodm Albumin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Human Bloodm Albumin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Human Bloodm Albumin Sales Market Share by Country (2020-2031)

Figure 22. North America Human Bloodm Albumin Revenue Market Share by Country (2020-2031)

Figure 23. United States Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Human Bloodm Albumin Sales Market Share by Country (2020-2031)

Figure 26. Europe Human Bloodm Albumin Revenue Market Share by Country (2020-2031)

Figure 27. Germany Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Human Bloodm Albumin Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Human Bloodm Albumin Revenue Market Share by Region (2020-2031)

Figure 34. China Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Human Bloodm Albumin Sales Market Share by Country (2020-2031)

Figure 42. Latin America Human Bloodm Albumin Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Middle East and Africa Human Bloodm Albumin Sales Market Share by Country (2020-2031)

Figure 47. Middle East and Africa Human Bloodm Albumin Revenue Market Share by Country (2020-2031)

Figure 48. Turkey Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. UAE Human Bloodm Albumin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Global Sales Market Share of Human Bloodm Albumin by Type (2020-2031)

Figure 52. Global Revenue Market Share of Human Bloodm Albumin by Type (2020-2031)

Figure 53. Global Human Bloodm Albumin Price (US$/Kg) by Type (2020-2031)

Figure 54. Global Sales Market Share of Human Bloodm Albumin by Application (2020-2031)

Figure 55. Global Revenue Market Share of Human Bloodm Albumin by Application (2020-2031)

Figure 56. Global Human Bloodm Albumin Price (US$/Kg) by Application (2020-2031)

Figure 57. Human Bloodm Albumin Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Plasma Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Albumin Market Research Report 2025

Global Albumin as Excipient Market Insights Forecast to 2030

Albumin Excipient Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical Excipient Albumin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Albumin Solution Market Research Report 2024

Global rHu Albumin Market Research Report 2024

Global Blood Banking and Blood Products Market Research Report 2024

Global Albumin Pharmaceutical Preparations Market Research Report 2024

Global Human Plasma Protein Products Market Research Report 2024

Global Plasma Protein Products Market Research Report 2024

Human Albumin Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Blood Products Market Research Report 2025

Global Albumin Testing Market Research Report 2024

Human Serum Albumin Fusion Protein Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Human Placental Blood Albumin Market Research Report 2024

Global Human Serum and Plasma Market Research Report 2024

Global Recombinant Human Albumin Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions